文献速递艾滋病与性传播感染医院感染防控

早期抗逆转录病毒治疗对胃肠道组织驻留记忆CD4+ T细胞的影响

Impact of early antiretroviral treatment on tissue resident memory CD4+ T cells in the gastrointestinal tract.
PubMed 文献 · J Infect Dis · 2026-07-16

本研究在纵向队列中嵌套横断面分析,探讨急性HIV-1感染及抗逆转录病毒治疗对乙状结肠组织驻留记忆CD4+ T细胞(CD4+ TRM)的影响。发现乙状结肠CD4+ TRM高表达CCR5,且 despite 长期ART仍被耗竭/未补充,与短链脂肪酸产生菌减少、机会性致病菌增加及全身炎症标志物升高相关。结论提示CD4+ TRM可能是HIV-1早期黏膜靶点,其持续耗竭导致黏膜屏障功能下降。

要点

  • 乙状结肠CD4+ TRM高表达CCR5,提示对HIV-1易感。
  • 无论急性感染期何时启动ART,乙状结肠CD4+ TRM均持续耗竭/未补充。
  • CD4+ TRM耗竭与短链脂肪酸产生菌减少、Desulfovibrio增加及全身炎症相关。

核心结论

  • 乙状结肠CD4+ TRM可能是HIV-1感染的早期黏膜靶点,其持续耗竭导致黏膜屏障功能下降,需开发恢复CD4+ TRM的治疗策略。

研究设计与样本

  • 纵向队列中的嵌套横断面研究。

主要发现

  • 乙状结肠CD4+ TRM(CD69+CD103+)较CD4+非TRM(CD69-CD103-)高表达CCR5,提示对HIV-1易感性增加。
  • 乙状结肠CD4+ TRM(而非CD4+非TRM) despite 长期ART仍被耗竭/未补充,与急性HIV感染期间启动治疗的Fiebig(F)阶段无关。
  • 若在FI/II期启动治疗,乙状结肠总CD4+ T细胞丰度与未感染HIV者相当;若在>FIII期启动治疗则显著降低,提示CD4+ TRM优先早期耗竭/未补充。
  • 乙状结肠CD4+ TRM丢失/未补充与短链脂肪酸产生共生菌丰度降低、机会性致病菌Desulfovibrio丰度增加及驱动非AIDS死亡的全身炎症可溶性标志物升高相关。

临床怎么用

  • 急性HIV感染期尽早启动ART可能有助于保留黏膜CD4+ T细胞总体丰度,但CD4+ TRM持续耗竭提示需探索恢复黏膜免疫的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tissue resident memory CD4+ T cells (CD4+ TRM) are long-lived, seldom-circulating cells that reside for long periods in most tissues. TRM can mount rapid, antigen-specific responses to pathogens and contribute to mucosal barrier homeostasis by regulating commensal interactions. At the intestinal mucosa, the main site of early HIV replication, CD4+ TRM may serve as virus targets; however, limited data are available regarding their dynamics during acute HIV-1 infection and antiretroviral treatment. METHODS: Nested cross-sectional study within a longitudinal cohort. RESULTS: Sigmoid CD4+ TRM (CD69+CD103+) had a higher expression of CCR5 compared to CD4+ non-TRM (CD69-CD103-), suggestive of increased susceptibility to HIV-1 infection. Consistent with this, sigmoid CD4+ TRM but not CD4+ non-TRM were depleted/non-replenished despite long-term ART, regardless of the Fiebig (F) stage treatment was initiated during acute HIV infection. In contrast, overall sigmoid CD4+ T-cells were comparable in abundance with people living without HIV if treatment was initiated in FI/II, but were significantly decreased if treatment was initiated >FIII, suggesting preferential early depletion/non-replenishment of CD4+ TRM. The loss/non-replenishment of sigmoid CD4+ TRM was associated with a lower abundance of short-chain fatty acid producing commensal bacteria that are crucial for the maintenance of mucosal homeostasis, a higher abundance of opportunistic pathobionts Desulfovibrio, and increased soluble biomarkers of systemic inflammation that drive non-AIDS mortality. CONCLUSION: Sigmoid CD4+ TRM may be early mucosal targets of HIV-1 infection and that their persistent depletion contributes to decreased mucosal barrier function, warranting development of therapeutic strategies that can restore CD4+ TRM during HIV treatment.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Vimonpatranon S, Ssemaganda A, Phuang-Ngern Y, et al. Impact of early antiretroviral treatment on tissue resident memory CD4+ T cells in the gastrointestinal tract. J Infect Dis. 2026. PMID: 42457178. doi:10.1093/infdis/jiag358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。